Research Article
Fetal and Maternal Outcomes of Planned Pregnancy in Patients with Systemic Lupus Erythematosus: A Retrospective Multicenter Study
Table 1
Maternal and fetal outcomes in pregnant women with SLE.
| Fetal adverse events | N | % |
| Preterm birth | 54 | 22.2 | Intrauterine growth retardation | 36 | 14.8 | Fetal distress | 27 | 11.1 | Fetal loss | 12 | 4.9 | Spontaneous abortion | 1 | 0.4 | Therapeutic abortion | 5 | 2.1 | Stillbirth | 6 | 2.5 | Neonatal death | 0 | 0 | Maternal adverse events | | | Disease flares | 52 | 21.4 | In the first trimester | 8 | 3.3 | In the second trimester | 15 | 6.2 | In the third trimester | 29 | 11.9 | SLEPDAI max > 4 | | | 5~9 | 45 | 18.5 | 10~14 | 6 | 2.5 | ≥15 | 1 | 0.4 | Pregnancy-induced hypertension | 29 | 11.9 | Gestational hypertension | 3 | 1.2 | Preeclampsia | 26 | 10.7 | Eclampsia | 0 | 0 |
|
|